The small intestinal bacterial overgrowth (SIBO) diagnostics market size is projected to reach US$ 266.81 million by 2031 from US$ 155.60 million in 2023. The market is expected to register a CAGR of 4.8% during 2023–2031. Next-generation sequencing technologies to diagnose SIBO is likely to remain key trend in the market.
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Analysis
Increasing incidence of SIBO, rising demand for non-invasive diagnostics tests, and technological advancements in diagnostic tests are fueling the growth of the small intestinal bacterial overgrowth (SIBO) diagnostics market. In addition, the growing focus on gut health and digestive health, expansion of healthcare infrastructure, and growing awareness and education about SIBO among healthcare professionals and patients are driving the growth of the small intestinal bacterial overgrowth (SIBO) diagnostics market
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Overview
Geographically, Asia Pacific is expected to register highest CAGR in the forecast period 2023-2031. India is among the fastest-developing nations in the world and is among the top leading countries of Asia Pacific. India is the fastest developing country in the Asia Pacific region. It has well-established companies operating in the biotechnology and medical device industry. Also, the a rising number of startups that are introducing laboratory equipment that utilizes the latest technologies. Whereas, rising cases of diarrhea, SIBO, and gastrointestinal diseases widen growth opportunities for India's small intestinal bacterial overgrowth (SIBO) diagnostics market. Similarly, the increasing number of hospitals and diagnostics laboratories across the country is likely to increase demand for modernized diagnostic instruments and equipment, offering a favorable environment for India small intestinal bacterial overgrowth diagnostics market during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market: Strategic Insights
Market Size Value in US$ 138,324.23 thousand in 2020 Market Size Value by US$ 194,604.51 thousand by 2028 Growth rate CAGR of 4.4% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market: Strategic Insights
Market Size Value in | US$ 138,324.23 thousand in 2020 |
Market Size Value by | US$ 194,604.51 thousand by 2028 |
Growth rate | CAGR of 4.4% from 2021-2028 |
Forecast Period | 2021-2028 |
Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystSmall Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Drivers and Opportunities
Increasing Prevalence of Irritable Bowel Syndrome (IBS) to Favor Market
Irritable bowel syndrome (IBS) is the commonly diagnosed gastrointestinal disorder with abdominal pain and altered bowel habits resulting with associated symptoms such as bloating, malabsorption, and systemic symptoms. Crohn's disease and ulcerative colitis are types of IBS. It causes swelling in the digestive tract, which can cause abdominal pain, diarrhea, fatigue, weight loss, and malnutrition. According to MedlinePlus, Crohn's disease is most prevalent in Western Europe and North America, with a prevalence rate of 100 to 300 per 100,000 people. According to the Medscape data, the incidence of ulcerative colitis in the US is 10.4–12 cases per 100,000 people, and the prevalence rate is 35–100 cases per 100,000 people. As compared to Crohn disease, ulcerative colitis is three times more common. IBD is thought to be a result of a multitude of environmental and bacterial interactions with immune-mediated factors in a genetically susceptible host. The increasing prevalence of IBS across the world is due to the changing lifestyle and dietary habits. Small intestinal bacterial overgrowth (SIBO) is widely associated with the IBS. Thus increasing prevalence of IBS fuelis the growth of the SIBO diagnostics market as it increases the prevalence of SIBO.
Development of Capsule Technology act as an Opportunity for Market Growth
The growing technological developments in the field of medical devices have offered various innovative products to diagnose several complex human health conditions. Thus, to diagnose SIBO, an innovative orally ingested capsule technology is in the developmental process. It is designed in a way to measure in vivo hydrogen and carbon-di-oxide after ingestion of a carbohydrate meal and provide a technologically updated alternative to the current breath hydrogen test. It is expected that the capsule technology will help in diagnosing samples of small bowel bacteria. Thus, the introduction of capsule technology is likely to emerge in the coming future and contribute to direct and accurate evaluation of SIBO and offer vital growth opportunities for the market’s growth.
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Report Segmentation Analysis
Key segments that contributed to the derivation of the small intestinal bacterial overgrowth (SIBO) diagnostics market analysis are product, and end user.
- Based on product, the small intestinal bacterial overgrowth (SIBO) diagnostics market is divided into breath testing, small intestine aspirate and fluid culture test, blood test, and others. The types of breath tests are further sub-categorized as 14C xylose breath test, hydrogen breath test, 14C glycocholic acid breath, and others. The breath testing segment held the largest market share in 2023.
- Based on type, the small intestinal bacterial overgrowth (SIBO) diagnostics market is divided into hydrogen-predominant SIBO, methane-predominant SIBO, and recurrent SIBO. The hydrogen-predominant SIBO segment held the largest market share in 2023.
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Share Analysis by Geography
The geographic scope of the small intestinal bacterial overgrowth (SIBO) diagnostics market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the market. North America is the largest market in the forecast period due to the increasing incidence of SIBO in the countries, growing government support, and increasing number of product introductions. In addition, rising demand for advanced diagnostic infrastructure is also likely to accelerate market growth during the forecast period. The US is the largest and fastest-growing country for the small intestinal bacterial overgrowth (SIBO) diagnostics market in the global market. The market's growth is primarily attributed to the increasing prevalence of conditions such as immunodeficiency syndromes and pancreatic exocrine insufficiency amongst others. Growing prevalence of risk factors associated with the SIBO are also expected to drive the prevalence of the condition, which will eventually offer favorable environment for growth of US small intestinal bacterial overgrowth diagnostics market
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Report Scope
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market News and Recent Developments
The Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the small intestinal bacterial overgrowth (SIBO) diagnostics market are listed below:
- Owlstone Medical launched OMED Health, a dedicated, patient-centric brand and digital platform that will offer patients and clinicians access to breath-based diagnostic tests, point-of-care (PoC) devices and support resources for a range of conditions. Initially focused on digestive disease, OMED Health will help individuals with gut health issues have an improved quality of life by enabling better, and faster, understanding and management of their conditions. (Source: Owlstone Medical, Press Release, April 2023)
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Report Coverage and Deliverables
The “Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Small intestinal bacterial overgrowth (SIBO) diagnostics market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Small intestinal bacterial overgrowth (SIBO) diagnostics market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Small intestinal bacterial overgrowth (SIBO) diagnostics market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the small intestinal bacterial overgrowth (SIBO) diagnostics market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Diagnosis ; Type , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
North America dominated the small intestinal bacterial overgrowth (SIBO) diagnostics market in 2023.
Increasing Prevalence of Irritable Bowel Syndrome (IBS) and SIBO and advantages of breath test are among the most influential factors responsible for the market growth.
Next-generation sequencing technologies to diagnose SIBO is likely to remain key trends in the small intestinal bacterial overgrowth (SIBO) diagnostics market.
Genova Diagnostics, SIBO Diagnostics, Commonwealth Diagnostics International, Aerodiagnostics, LLC, SIBOTest, Metabolic Solutions, Inc., Pivotal Diagnostics, DirectLabs, LLC, Vibrant Wellness, and Health Associates Medical Group are among the key players operating in the market.
The small intestinal bacterial overgrowth (SIBO) diagnostics market is estimated to reach US$ 226.81 million in 2031.
The small intestinal bacterial overgrowth (SIBO) diagnostics market is anticipated to record a CAGR of 4.8% during 2023–2031.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
Jun 2024
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Jun 2024
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Jun 2024
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Jun 2024
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Jun 2024
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Jun 2024
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2024
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
Jun 2024
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)